Iproclozide

This classification denotes a monoamine oxidase inhibitor and antidepressant agent with the molecular formula C11H15ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1II9D6CB3J, chemically known as acetic acid, (p-chlorophenoxy)-, 2-isopropylhydrazide but generally known as iproclozide, which bears US NIH Compound Identifier 19063. European Medicines Agency schedules Iproclozide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08280MIG. The term IPROCLOZIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules iproclozide in its Anatomical Therapeutic Chemical (ATC) Classification. IPROCLOZIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule iproclozide under HS 29280090 and SITC 51486. As of Q4 2014, IPROCLOZIDE remains the US FDA Preferred Term for this commodity. Iproclozide bears US NLM identifiers UMLS ID C0063841 and NCI Concept Code C65955. SMILES: CC(C)NNC(=O)COC1=CC=C(C=C1)Cl.